01606nam 2200397Ia 450 991069883850332120090521122751.0(CKB)5470000002397482(OCoLC)334847937(EXLCZ)99547000000239748220090521d2004 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] use of nucleic acid tests on pooled and individual samples from donors of whole blood and plasma components (including source plasma and source leukocytes) to adequately and appropriately reduce the risk of transmission of HIV-1 and HCVRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2004]i, 11 pages digital, PDF fileTitle from PDF title page (viewed on May 21, 2009)."October 2004".Includes bibliographic references (page 11).Guidance for industry Nucleic acidsUnited StatesTestingBloodExaminationUnited StatesHIV (Viruses)United StatesPreventionNucleic acidsTesting.BloodExaminationHIV (Viruses)Prevention.Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698838503321Guidance for industry3434577UNINA